subscribeSubscribe
Novitium`s Generic Alendronate Sodium Receives Receives Approval in the U.S.

Novitium`s Generic Alendronate Sodium Receives Receives Approval in the U.S.
FDA
11 May 2023
Share Share
New Data From Amgen`S Prolia® (Denosumab) Demonstrates Significant Reduction

New Data From Amgen`S Prolia® (Denosumab) Demonstrates Significant Reduction
PR NEWSWIRE
08 May 2023
Share Share
Merck Beats Suits Tying Thighbone Fractures to Osteoporosis Drug

Merck Beats Suits Tying Thighbone Fractures to Osteoporosis Drug
BLOMMBERG LAW
25 Mar 2022
Share Share
Merck Fosamax case gets another shot at preemption argument

Merck Fosamax case gets another shot at preemption argument
Eric Sagonowsky FIERCE PHARMA
22 May 2019
Share Share
U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug

U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drug
Andrew Chung YAHOO
21 May 2019
Share Share
Amgen sets $21,900 annual price for new Evenity bone drug

Amgen sets $21,900 annual price for new Evenity bone drug
Natalie Grover ENDPTS
17 Apr 2019
Share Share
Once spurned, Amgen wins the FDA over with its osteoporosis drug Evenity

Once spurned, Amgen wins the FDA over with its osteoporosis drug Evenity
Natalie Grover ENDPTS
09 Apr 2019
Share Share
The Ripples Of The Fosamax Reversal

The Ripples Of The Fosamax Reversal
Eric Alexander DRUGANDDEVICE
07 Mar 2019
Share Share
List of Paragraph IV Patent Certifications Feb-12, 2019

List of Paragraph IV Patent Certifications Feb-12, 2019
FDA
13 Feb 2019
Share Share
U.S. Supreme Court could side with Merck over Fosamax lawsuits

U.S. Supreme Court could side with Merck over Fosamax lawsuits
Andrew Chung REUTERS
07 Jan 2019
Share Share